Community treatment of psych patients tied to less mortality

Community treatment of psych patients tied to less mortality
For patients with psychiatric disorders, community treatment orders correlate with a reduction in mortality, according to research published online Nov. 12 in CMAJ, the journal of the Canadian Medical Association.

(HealthDay)—For patients with psychiatric disorders, community treatment orders correlate with a reduction in mortality, according to research published online Nov. 12 in CMAJ, the journal of the Canadian Medical Association.

Steve Kisely, M.D., Ph.D., from Dalhousie University in Halifax, Canada, and colleagues conducted a population-based survival analysis to examine whether community treatment could reduce all-cause mortality among patients with psychiatric disorders. The study involved 2,958 patients with community treatment orders and 2,958 matched controls, all of whom were patients in in Western Australia.

Cases and controls had an average age of 36.7 years, and 63.7 percent were male. The researchers found that, among participants, schizophrenia and other non-affective psychoses were the most common diagnoses (73.4 percent). During the study, a total of 492 patients (8.3 percent) died. Patients with community treatment orders had significantly lower all-cause mortality at one, two, and three years, compared with controls, with an adjusted hazard ratio of 0.62 at two-years. The greatest reduction in mortality came from physical illnesses, including cancer, cardiovascular disease, or diseases of the , but the association disappeared when adjusting for increased outpatient and community contacts with psychiatric services.

"Community treatment orders might reduce mortality associated with preventable among patients with psychiatric disorders," the authors write. "Such a reduction may be partly explained by increased contact with health services in the community and better access to medically necessary treatments."

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Methotrexate use linked to reduced mortality in RA

Oct 14, 2012

(HealthDay)—Use of methotrexate for one year or more is associated with a reduction in the risk of mortality for patients with rheumatoid arthritis (RA), according to a study published online Oct. 8 in ...

Statin use at cancer diagnosis linked to lower mortality

Nov 08, 2012

(HealthDay)—For patients with cancer, statin use prior to diagnosis correlates with reduced all-cause and cancer-related mortality, according to a study published in the Nov. 8 issue of the New England Jo ...

NAFLD independently linked to cardiovascular disease

Jun 07, 2012

(HealthDay) -- Nonalcoholic fatty liver disease (NAFLD) is independently associated with an increased risk of cardiovascular disease (CVD), but it is not associated with a statistically significantly increased ...

Clopidogrel after MI less effective in diabetes patients

Sep 05, 2012

(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue ...

Recommended for you

Giving emotions to virtual characters

10 hours ago

Researchers at the Autonomous University of the State of Mexico (UAEM) were able to simulate human facial expressions in virtual characters and use them in order to create better environments within a virtual ...

Emotion-tracking software aims for "mood-aware" internet

10 hours ago

Emotions can be powerful for individuals. But they're also powerful tools for content creators, such as advertisers, marketers, and filmmakers. By tracking people's negative or positive feelings toward ads—via ...

The emotional appeal of stand-up comedy

11 hours ago

Comics taking to the stage at the Edinburgh Fringe this week should take note: how much of a hit they are with their audiences won't be down to just their jokes. As Dr Tim Miles from the University of Surrey has discovered, ...

User comments